| Schedule of Reconciliation of the Weighted Average Number of Common Shares Outstanding used in Calculating Basic and Diluted Net Loss Per Share |
The
following is a reconciliation of the weighted average number of common shares outstanding used in calculating basic and diluted net loss
per share (in thousands):
Schedule
of Reconciliation of the Weighted Average Number of Common Shares Outstanding used in Calculating Basic and Diluted Net Loss
Per Share
| | |
June
30, 2026 | | |
June
30, 2025 | | |
June
30, 2026 | | |
June
30, 2025 | |
| | |
For
the three months ended | | |
For
the six months ended | |
| | |
June
30, 2026 | | |
June
30, 2025 | | |
June
30, 2026 | | |
June
30, 2025 | |
| Loss from continuing
operations after income taxes | |
$ | (3,051 | ) | |
$ | (4,472 | ) | |
$ | (8,226 | ) | |
$ | (9,150 | ) |
| Income
from discontinued operations, net of tax | |
| - | | |
| - | | |
| - | | |
| 8,644 | |
| Net
loss | |
$ | (3,051 | ) | |
$ | (4,472 | ) | |
$ | (8,226 | ) | |
$ | (506 | ) |
| Weighted average common shares outstanding: | |
| | | |
| | | |
| | | |
| | |
| Basic | |
| 14,016 | | |
| 4,154 | | |
| 13,171 | | |
| 3,840 | |
| Diluted | |
| 14,016 | | |
| 4,154 | | |
| 13,171 | | |
| 3,840 | |
| Net earnings (loss) per share: | |
| | | |
| | | |
| | | |
| | |
| Loss
from continuing operations, basic and diluted | |
$ | (0.22 | ) | |
$ | (1.08 | ) | |
$ | (0.62 | ) | |
$ | (2.38 | ) |
| Income
from discontinued operations, basic and diluted | |
$ | - | | |
$ | - | | |
$ | - | | |
$ | 2.25 | |
| Net
loss (earnings) per share, basic and diluted | |
$ | (0.22 | ) | |
$ | (1.08 | ) | |
$ | (0.62 | ) | |
$ | (0.13 | ) |
|
| Schedule of Anti-dilutive Securities Excluded from the Income Per Share Computation |
The
following table represents the number of securities excluded from the income per share computation as a result of their anti-dilutive
effect (in thousands):
Schedule of Anti-dilutive Securities Excluded from the Income Per Share Computation
| Anti-dilutive securities | |
June 30, 2026 | | |
June 30, 2025 | | |
June 30, 2026 | | |
June 30, 2025 | |
| | |
For the three months ended | | |
For the six months ended | |
| Anti-dilutive securities | |
June 30, 2026 | | |
June 30, 2025 | | |
June 30, 2026 | | |
June 30, 2025 | |
| Common stock purchase warrants | |
| 997 | | |
| 174 | | |
| 997 | | |
| 174 | |
| Stock options | |
| 478 | | |
| 445 | | |
| 478 | | |
| 445 | |
| Convertible notes | |
| 13,773 | | |
| - | | |
| 13,773 | | |
| - | |
| Anti-dilutive securities | |
| 15,248 | | |
| 619 | | |
| 15,248 | | |
| 619 | |
|